These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33153626)

  • 21. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
    Fleming AB; Raabe V
    J Clin Virol; 2020 Jun; 127():104388. PubMed ID: 32361326
    [No Abstract]   [Full Text] [Related]  

  • 22. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
    Accorsi P; Berti P; de Angelis V; De Silvestro G; Mascaretti L; Ostuni A;
    Transfus Apher Sci; 2020 Aug; 59(4):102817. PubMed ID: 32532691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
    Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
    Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
    J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
    J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
    Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
    Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
    Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
    Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 30. Convalescent plasma for patients with COVID-19.
    Zeng F; Chen X; Deng G
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12528. PubMed ID: 32398379
    [No Abstract]   [Full Text] [Related]  

  • 31. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19.
    Rubin R
    JAMA; 2020 Jun; 323(21):2114-2117. PubMed ID: 32352484
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020.
    Mehew J; Johnson R; Roberts D; Harvala H
    Euro Surveill; 2020 Nov; 25(45):. PubMed ID: 33183404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
    Majbour N; El-Agnaf O
    Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
    Zeng QL; Yu ZJ; Gou JJ; Li GM; Ma SH; Zhang GF; Xu JH; Lin WB; Cui GL; Zhang MM; Li C; Wang ZS; Zhang ZH; Liu ZS
    J Infect Dis; 2020 Jun; 222(1):38-43. PubMed ID: 32348485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convalescent plasma as a potential therapy for COVID-19.
    Chen L; Xiong J; Bao L; Shi Y
    Lancet Infect Dis; 2020 Apr; 20(4):398-400. PubMed ID: 32113510
    [No Abstract]   [Full Text] [Related]  

  • 39. Deployment of convalescent plasma for the prevention and treatment of COVID-19.
    Bloch EM; Shoham S; Casadevall A; Sachais BS; Shaz B; Winters JL; van Buskirk C; Grossman BJ; Joyner M; Henderson JP; Pekosz A; Lau B; Wesolowski A; Katz L; Shan H; Auwaerter PG; Thomas D; Sullivan DJ; Paneth N; Gehrie E; Spitalnik S; Hod EA; Pollack L; Nicholson WT; Pirofski LA; Bailey JA; Tobian AA
    J Clin Invest; 2020 Jun; 130(6):2757-2765. PubMed ID: 32254064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020.
    Harvala H; Mehew J; Robb ML; Ijaz S; Dicks S; Patel M; Watkins N; Simmonds P; Brooks T; Johnson R; Gopal R; Roberts DJ; Zambon M;
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.